SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux

Annual Review of Physiology

Volumn 80, Issue , 2018, Pages 95-116

  Shen, Wen Jun ^a,b   Azhar, Salman ^a,b   Kraemer, Fredric B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

HDL; HDL receptor; Reverse cholesterol transport; Selective cholesterol uptake

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR BI; VITAMIN; CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTORS; LIPOPROTEIN RECEPTOR;

APOPTOSIS; ATHEROSCLEROSIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CARDIOVASCULAR INFLAMMATION; CHOLESTEROL TRANSPORT; FEMALE FERTILITY; GENE EXPRESSION REGULATION; GENE STRUCTURE; HEART INFARCTION; HOST CELL; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; THROMBOCYTE FUNCTION; ANIMAL; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CD36 ANTIGENS; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; RECEPTORS, LIPOPROTEIN;

EID: 85041917914     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021317-121550     Document Type: Review

References (159)

1. Ikonen E. 2008. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell. Biol. 9:125-38
2. Cooper G. 2000. The Cell: A Molecular Approach. Cary, NC: Sinauer Assoc.
3. Incardona JP, Eaton S. 2000. Cholesterol in signal transduction. Curr. Opin. Cell Biol. 12:193-203
4. Carmena R, Duriez P, Fruchart JC. 2004. Atherogenic lipoprotein particles in atherosclerosis. Circulation 109:III2-7
5. Rosenson RS, Brewer HB Jr., Davidson WS, Fayad ZA, Fuster V, et al. 2012. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:1905-19
6. ShenWJ, Azhar S, Kraemer FB. 2016. ACTH regulation of adrenal SR-B1. Front. Endocrinol. 7:42
7. ShenWJ, Azhar S, Kraemer FB. 2016. Lipid droplets and steroidogenic cells. Exp. Cell Res. 340:209-14
8. Kraemer FB, ShenWJ, Harada K, Patel S, Osuga J, et al. 2004. Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis. Mol. Endocrinol. 18:549-57
9. Kraemer FB, ShenWJ, Natu V, Patel S, Osuga J, et al. 2002. Adrenal neutral cholesteryl ester hydrolase: identification, subcellular distribution, and sex differences. Endocrinology 143:801-6
10. Lin Y, Hou X, ShenWJ, Hanssen R, Khor VK, et al. 2016. SNARE-mediated cholesterol movement to mitochondria supports steroidogenesis in rodent cells. Mol. Endocrinol. 30:234-47
11. Freeman DA. 1987. Regulation of the cholesterol ester cycle of cultured Leydig tumor cells. Eur. J. Biochem. 164:351-56
12. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. 2009. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res. 50:S189-94
13. Annema W, Tietge UJ. 2012. Regulation of reverse cholesterol transport-a comprehensive appraisal of available animal studies. Nutr. Metab. 9:25
14. Ono K. 2012. Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J. Cardiol. 60:339-43
15. Phillips MC. 2014. Molecular mechanisms of cellular cholesterol efflux. J. Biol. Chem. 289:24020-29
16. Calvo D, VegaMA. 1993. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J. Biol. Chem. 268:18929-35
17. Acton SL, Scherer PE, Lodish HF, Krieger M. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269:21003-9
18. Duggan A, Marie R, Callard I. 2002. Expression of SR-BI (Scavenger Receptor Class B Type I) in turtle (Chrysemys picta) tissues and other nonmammalian vertebrates. J. Exp. Zool. 292:430-34
19. ShenWJ, Hu J, Hu Z, Kraemer FB, Azhar S. 2014. Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions. Metabolism 63:875-86
20. Means TK. 2010. Fungal pathogen recognition by scavenger receptors in nematodes and mammals. Virulence 1:37-41
21. Herboso L, Talamillo A, Pérez C, Barrio R. 2011. Expression of the Scavenger Receptor Class B type I (SR-BI) family in Drosophila melanogaster. Int. J. Dev. Biol. 55:603-11
22. Sakudoh T, Kuwazaki S, Iizuka T, Narukawa J, Yamamoto K, et al. 2013. CD36 homolog divergence is responsible for the selectivity of carotenoid species migration to the silk gland of the silkworm Bombyx mori. J. Lipid Res. 54:482-95
23. Nichols Z, Vogt RG. 2008. The SNMP/CD36 gene family in Diptera, Hymenoptera and Coleoptera: Drosophila melanogaster, D. pseudoobscura, Anopheles gambiae, Aedes aegypti, Apis mellifera, and Tribolium castaneum. Insect Biochem. Mol. Biol. 38:398-415
24. Kiefer C, Sumser E, Wernet MF, von Lintig J. 2002. A class B scavenger receptor mediates the cellular uptake of carotenoids. PNAS 99:10581-86
25. Tabunoki H, Sugiyama H, Tanaka Y, Fujui H, Banno Y, et al. 2002. Isolation, characterization, and cDNA sequence of a carotenoid binding protein from the silk gland of Bombyx mori. J. Biol. Chem. 277:32133-40
26. Sakudoh T, Iizuka T, Narukawa J, Sezutsu H, Kobayashi I, et al. 2010. A CD36-related transmembrane protein is coordinated with an intracellular lipid-binding protein in selective carotenoid transport for cocoon coloration. J. Biol. Chem. 285:7739-51
27. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
28. Pittman RC, Knecht TP, Rosenbaum MS, Taylor CA Jr. 1987. A nonendocytotic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J. Biol. Chem. 262:2443-50
29. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-20
30. VarbanML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, et al. 1998. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. PNAS 95:4619-24
31. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. 1997. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. PNAS 94:12610-15
32. Van Eck M, Twisk J, Hoekstra M, Van Rij BT, Van der Lans CA, et al. 2003. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J. Biol. Chem. 278:23699-705
33. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. 1997. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387:414-17
34. Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, et al. 1999. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 274:7165-71
35. Wang N, Arai T, Ji Y, Rinninger F, Tall AR. 1998. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273:32920-26
36. During A, Dawson H, Harrison E. 2005. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J. Nutr. 135:2305-12
37. Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, et al. 2006. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J. Biol. Chem. 281:4739-45
38. Rigotti A, Acton S, Krieger M. 1995. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270:16221-24
39. Saddar S, Carriere V, Lee W, Tanigaki K, Yuhanna I, et al. 2013. Scavenger Receptor Class B Type I (SR-BI) is a plasma membrane cholesterol sensor. Circ. Res. 112:140-51
40. Tsugita M, Morimoto N, Tashiro M, Kinoshita K, Nakayama M. 2017. SR-B1 is a silica receptor that mediates canonical inflammasome activation. Cell Rep. 18:1298-311
41. Burlone M, Budkowska A. 2009. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 90:1055-70
42. Barth H, Schnober E, Neumann-Haefelin C, Thumann C, Zeisel M, et al. 2008. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol. 82:3466-79
43. Osada Y, Sunatani T, Kim I, Nakanishi Y, Shiratsuchi A. 2009. Signalling pathway involving GULP, MAPK and Rac1 for SR-BI-induced phagocytosis of apoptotic cells. J. Biochem. 145:387-94
44. Miettinen H, Rayburn H, Krieger M. 2001. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J. Clin. Investig. 108:1717-22
45. Ma Y, AshrafM, Podrez E. 2010. Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood 116:1932-41
46. Zimman A, Podrez E. 2010. Regulation of platelet function by class B scavenger receptors in hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 30:2350-56
47. Al-Jarallah A, Trigatti B. 2010. A role for the scavenger receptor, class B type I in high density lipoprotein dependent activation of cellular signaling pathways. Biochim. Biophys. Acta 1801:1239-49
48. Saddar S MC, Shaul PW. 2010. Signaling by the high-affinity HDL receptor B type I. Arterioscler. Thromb. Vasc. Biol. 30:144-50
49. Pei Y, ChenX, Aboutouk D, FullerM, Dadoo O, et al. 2013. SR-BI in bonemarrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction. PLOS ONE 8:e72492
50. Webb NR, de Villiers WJ, Connell PM, de Beer FC, van derWesthuyzen DR. 1997. Alternative forms of the scavenger receptor BI (SR-BI). J. Lipid Res. 38:1490-95
51. Trigatti BL. 2017. SR-B1 and PDZK1: partners in HDL regulation. Curr. Opin. Lipidol. 28:201-8
52. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, et al. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273:15241-48
53. Carithers LJ, Moore HM. 2015. The Genotype-Tissue Expression (GTEx) Project. Biopreserv. Biobank. 13:307-8
54. Chen R, Jiang X, Sun D, Han G, Wang F, et al. 2009. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8:651-61
55. Viñals M, Xu S, Vasile E, KriegerM. 2003. Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of the effects on HDL binding and selective lipid uptake. J. Biol. Chem. 278:5325-32
56. Bian Y, Song C, Cheng K, Dong M, Wang F, et al. 2014. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteom. 96:253-62
57. Gaidukov L, Nager A, Xu S, PenmanM, Krieger M. 2011. Glycine dimerizationmotif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J. Biol. Chem. 286:18452-64
58. Neculai D, SchwakeM, Ravichandran M, Zunke F, CollinsRF, et al. 2013. Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36. Nature 504:172-76
59. Rasmussen JT, Berglund L, Rasmussen MS, Petersen TE. 1998. Assignment of disulfide bridges in bovine CD36. Eur. J. Biochem. 257:488-94
60. Yu M, Lau TY, Carr SA, KriegerM. 2012. Contributions of a disulfide bond and a reduced cysteine side chain to the intrinsic activity of the high-density lipoprotein receptor SR-BI. Biochemistry 51:10044-55
61. Hu J, Zhang Z, ShenWJ, Nomoto A, Azhar S. 2011. Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI. Biochemistry 50:10860-75
62. Yu M, Romer KA, Nieland TJ, Xu S, Saenz-Vash V, et al. 2011. Exoplasmic cysteine Cys384 of the HDL receptor SR-BI is critical for its sensitivity to a small-molecule inhibitor and normal lipid transport activity. PNAS 108:12243-48
63. Rigotti A, EdelmanER, Seifert P, Iqbal SN, DeMattosRB, et al. 1996. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J. Biol. Chem. 271:33546-49
64. Azhar S, Nomoto A, Reaven E. 2002. Hormonal regulation of adrenal microvillar channel formation. J. Lipid Res. 43:861-71
65. Rigotti A, Edelmann E, Seifert P, Iqbal S, DeMattos R, et al. 1996. Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J. Biol. Chem. 271:33545-49
66. Wang N, Weng W, Breslow JL, Tall AR. 1996. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J. Biol. Chem. 271:21001-4
67. Hu Z, Hu J, ShenWJ, Kraemer FB, Azhar S. 2015. A novel role of salt-inducible kinase 1 (SIK1) in the post-translational regulation of scavenger receptor class B type 1 activity. Biochemistry 54:6917-30
68. Sun Y, Wang N, Tall AR. 1999. Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. J. Lipid Res. 40:1799-805
69. Liu J, Voutilainen R, Heikkila P, Kahri AI. 1997. Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells. J. Clin. Endocrinol. Metab. 82:2522-27
70. Martin G, Pilon A, Albert C, Valle M, Hum DW, et al. 1999. Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells. Eur. J. Biochem. 261:481-91
71. Landschulz KT, Pathak RK, Rigotti A, KriegerM, Hobbs HH. 1996. Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J. Clin. Investig. 98:984-95
72. Azhar S, Nomoto A, Leers-Sucheta S, Reaven E. 1998. Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model. J. Lipid Res. 39:1616-28
73. Reaven E, Nomoto A, Leers-Sucheta S, Temel R, Williams DL, Azhar S. 1998. Expression andmicrovillar localization of scavenger receptor, class B, type I (a high density lipoprotein receptor) in luteinized and hormone-desensitized rat ovarian model. Endocrinology 139:2847-56
74. Reaven E, Zhan L, Nomoto A, Leers-Sucheta S, Azhar S. 2000. Expression and microvillar localization of scavenger receptor class B, type I (SR-BI) and selective cholesteryl ester uptake in Leydig cells from rat testis. J. Lipid Res. 41:343-56
75. Ljunggren SA, Levels JH, Hovingh K, Holleboom AG, Vergeer M, et al. 2015. Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1. Biochim. Biophys. Acta 1851:1587-95
76. Vergeer M, Korporaal SJ, Franssen R, Meurs I, Out R, et al. 2011. Genetic variant of the scavenger receptor BI in humans. N. Engl. J. Med. 364:136-45
77. Lopez D, McLean MP. 1999. Sterol regulatory element-binding protein-1a binds to cis elements in the promoter of the rat high density lipoprotein receptor SR-BI gene. Endocrinology 140:5669-81
78. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH. 1997. Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J. Biol. Chem. 272:33068-76
79. Malerød L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T. 2002. Oxysterol-activated LXR?/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem. Biophys. Res. Commun. 299:916-23
80. Lopez D, McLean MP. 2006. Activation of the rat scavenger receptor class B type I gene by PPAR?. Mol. Cell Endocrinol. 251:67-77
81. Schoonjans K, Annicotte JS, Huby T, Botrugno OA, Fayard E, et al. 2002. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep. 3:1181-87
82. LopezD, Sanchez MD, Shea-EatonW, McLeanMP. 2002. Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A. Endocrinology 143:2155-68
83. Lopez D, Sandhoff TW, McLean MP. 1999. Steroidogenic factor-1 mediates cyclic 3, 5-adenosine monophosphate regulation of the high density lipoprotein receptor. Endocrinology 140:3034-44
84. Shea-Eaton W, Lopez D, McLean MP. 2001. Yin yang 1 protein negatively regulates high-density lipoprotein receptor gene transcription by disrupting binding of sterol regulatory element binding protein to the sterol regulatory element. Endocrinology 142:49-58
85. Sporstol M, Tapia G, Malerod L, Mousavi SA, Berg T. 2005. Pregnane X receptor-agonists downregulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I. Biochem. Biophys. Res. Commun. 331:1533-41
86. Temel RE, Trigatti B, DeMattos RB, Azhar S, Krieger M, Williams DL. 1997. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. PNAS 94:13600-5
87. Cao G, Zhao L, Stangl H, Hasegawa T, Richardson J, et al. 1999. Developmental and hormonal regulation of murine scavenger receptor, class B, type 1. Mol. Endocrinol. 13:1460-73
88. Vieira-vanBruggenD, Kalkman I, van Gent T, vanTol A, Jansen H. 1998. Induction of adrenal scavenger receptor BI and increased high density lipoprotein-cholesteryl ether uptake by in vivo inhibition of hepatic lipase. J. Biol. Chem. 273:32038-41
89. Mavridou S, Venihaki M, Rassouli O, Tsatsanis C, Kardassis D. 2010. Feedback inhibition of human scavenger receptor class B type I gene expression by glucocorticoid in adrenal and ovarian cells. Endocrinology 151:3214-24
90. Wang L, Jia XJ, JiangHJ, Du Y, Yang F, et al. 2013. MicroRNAs 185, 96, and 223 repress selective highdensity lipoprotein cholesterol uptake through posttranscriptional inhibition. Mol. Cell. Biol. 33:1956-64
91. Hu Z, ShenWJ, Kraemer FB, Azhar S. 2012. MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells. Mol. Cell. Biol. 32:5035-45
92. Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M. 1998. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor classBtype I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273:26338-48
93. NielandTJ, Xu S, Penman M, KriegerM. 2011. Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI. Biochemistry 50:1818-30
94. Thuahnai ST, Lund-Katz S, Dhanasekaran P, de la Llera-MoyaM, Connelly MA, et al. 2004. Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure. J. Biol. Chem. 279:12448-55
95. Bocharov A, Baranova I, Vishnyakova T, Remaley A, Csako G, et al. 2004. Targeting of scavenger receptor class B type I by synthetic amphipathic ?-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J. Biol. Chem. 279:36072-82
96. Thuahnai S, Lund-Katz S, Anantharamaiah G, Williams D, Phillips M. 2003. A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins. J. Lipid Res. 44:1132-42
97. Connelly M, Klein S, Azhar S, AbumradN, WilliamsD. 1999. Comparison of classBscavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoproteincholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274:41-47
98. Sun B, Boyanovsky B, Connelly M, Shridas P, van der Westhuyzen D, Webb N. 2007. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J. Lipid Res. 48:2560-70
99. Reaven E, Leers-Sucheta S, Nomoto A, Azhar S. 2001. Expression of scavenger receptor class B type 1 (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system. PNAS 98:1613-18
100. Reaven E, Nomoto A, Cortez Y, Azhar S. 2006. Consequences of over-expression of rat scavenger receptor, SR-BI, in an adrenal cell model. Nutr. Metab. 3:43
101. Reaven E, Cortez Y, Leers-Sucheta S, Nomoto A, Azhar S. 2004. Dimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissues. J. Lipid Res. 45:513-28
102. Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, KriegerM. 2003. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J. Biol. Chem. 278:52820-25
103. Hu Z, Hu J, Zhang Z, ShenW, Yun C, et al. 2013. Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+/H+ exchanger regulatory factors (NHERFs). J. Biol. Chem. 288:11416-35
104. Thuahnai ST, Lund-Katz S, Williams DL, Phillips MC. 2001. Scavenger receptor class B, type Imediated uptake of various lipids into cells. Influence of the nature of the donor particle interaction with the receptor. J. Biol. Chem. 276:43801-8
105. Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, PhillipsMC, Williams DL. 1999. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J. Biol. Chem. 274:20344-50
106. Silver DL, Wang N, Xiao X, Tall AR. 2001. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J. Biol. Chem. 276:25287-93
107. Reaven E, Tsai L, Azhar S. 1996. Intracellular events in the "selective" transport of lipoprotein-derived cholesteryl esters. J. Biol. Chem. 271:16208-17
108. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. 2009. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993-2000
109. Lewington S, WhitlockG, Clarke R, Sherliker P, Emberson J, et al. 2007. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 370:1829-39
110. Hu J, Zhang Z, Shen WJ, Azhar S. 2010. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr. Metab. 7:47
111. De la Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, et al. 1999. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J. Lipid Res. 40:575-80
112. Yancey PG, de la Llera-MoyaM, Swarnakar S, Monzo P, Klein SM, et al. 2000. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275:36596-604
113. Kellner-WeibelG, de la Llera-MoyaM, Connelly MA, Stoudt G, Christian AE, et al. 2000. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 39:221-29
114. Larrede S, Quinn CM, Jessup W, Frisdal E, Olivier M, et al. 2009. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler. Thromb. Vasc. Biol. 29:1930-36
115. Badeau RM, Metso J, Wahala K, Tikkanen MJ, Jauhiainen M. 2009. Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17?-estradiol fatty acyl esters. J. Steroid Biochem. Mol. Biol. 116:44-49
116. Linton MF, Tao H, Linton EF, Yancey PG. 2017. SR-BI: A multifunctional receptor in cholesterol homeostasis and atherosclerosis. Trends Endocrinol. Metab. 28:461-72
117. Williams DL, Temel RE, Connelly MA. 2000. Roles of scavenger receptor BI and APO A-I in selective uptake of HDL cholesterol by adrenal cells. Endocr. Res. 26:639-51
118. Williams D, Wong J, Hamilton R. 2002. SR-BI is required for microvillar channel formation and the localization of HDL particles to the surface of adrenocortical cells in vivo. J. Lipid Res. 43:544
119. Peng Y, Akmentin W, Connelly M, Lund-Katz S, Phillips M, Williams D. 2004. Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol. Biol. Cell 15:384-96
120. Yesilaltay A, Morales MG, Amigo L, Zanlungo S, Rigotti A, et al. 2006. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoproteinmetabolism and female fertility. Endocrinology 147:1577-88
121. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ. 2000. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptordeficient mouse. Arterioscler. Thromb. Vasc. Biol. 20:721-27
122. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. 2005. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Investig. 115:2870-74
123. ZhangW, Yancey PG, Su YR, Babaev VR, Zhang Y, et al. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108:2258-63
124. Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, et al. 2016. Rare variant in scavenger receptorBI raisesHDLcholesterol and increases risk of coronary heart disease. Science 351:1166-71
125. Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, et al. 2013. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab. 17:671-84
126. Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, et al. 2008. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ. Res. 102:480-87
127. Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. 2011. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 13:655-67
128. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, et al. 2012. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 15:545-53
129. Pfeiler S, Khandagale AB, Magenau A, NicholsM, HeijnenHF, et al. 2016. Distinct surveillance pathway for immunopathology during acute infection via autophagy and SR-BI. Sci. Rep. 6:34440
130. Ahras M, Naing T, McPherson R. 2008. Scavenger receptor class B type I localizes to a late endosomal compartment. J. Lipid Res. 49:1569-76
131. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, et al. 2004. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117:4837-48
132. McCarthy JJ, Lehner T, Reeves C, Moliterno DJ, Newby LK, et al. 2003. Association of genetic variants in theHDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J. Med. Genet. 40:453-58
133. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. 2010. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707-13
134. Yang X, Sethi A, Yanek LR, Knapper C, Nordestgaard BG, et al. 2016. SCARB1 gene variants are associated with the phenotype of combined high high-density lipoprotein cholesterol and high lipoprotein (a). Circ. Cardiovasc. Genet. 9:408-18
135. Hayashi AA, Webb J, Choi J, Baker C, Lino M, et al. 2011. Intestinal SR-BI is upregulated in insulinresistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 301:G326-37
136. Masson D, Koseki M, Ishibashi M, Larson CJ, Miller SG, et al. 2009. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. Arterioscler. Thromb. Vasc. Biol. 29:2054-60
137. Syder AJ, Lee H, Zeisel MB, Grove J, Soulier E, et al. 2011. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. J. Hepatol. 54:48-55
138. Zhu YZ, Qian XJ, Zhao P, Qi ZT. 2014. How hepatitis C virus invades hepatocytes: the mystery of viral entry. World J. Gastroenterol. 20:3457-67
139. Li Y, Kakinami C, Li Q, Yang B, Li H. 2013. Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI. PLOS ONE 8:e70390
140. Gutierrez-Pajares JL, Ben Hassen C, Chevalier S, Frank PG. 2016. SR-BI: Linking cholesterol and lipoprotein metabolism with breast and prostate cancer. Front. Pharmacol. 7:338
141. Schörghofer D, Kinslechner K, Preitschopf A, Schütz B, Röhrl C, et al. 2015. TheHDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. Reprod. Biol. Endocrinol. 13:88
142. Yuan B, Wu C, Wang X, Wang D, Liu H, et al. 2016. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer. Tumor Biol. 37:3581-88
143. Cao WM, Murao K, Imachi H, Yu X, Abe H, et al. 2004. A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res. 64:1515-21
144. Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, et al. 2011. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia 13:309-19
145. ZhengY, Liu Y, JinH, Pan S, Qian Y, et al. 2013. Scavenger receptorB1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited byHDL-mimetic nanoparticles. Theranostics 3:477-86
146. Mooberry LK, Sabnis NA, Panchoo M, Nagarajan B, Lacko AG. 2016. Targeting the SR-B1 receptor as a gateway for cancer therapy and imaging. Front. Pharmacol. 7:466
147. Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. 2010. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. J. Drug Target. 18:53-58
148. Yang S, Damiano MG, Zhang H, Tripathy S, Luthi AJ, et al. 2013. Biomimetic, synthetic HDL nanostructures for lymphoma. PNAS 110:2511-16
149. Farokhzad OC, Langer R. 2009. Impact of nanotechnology on drug delivery. ACS Nano 3:16-20
150. Counsell RE, Pohland RC. 1982. Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents. J. Med. Chem. 25:1115-20
151. Kader A, Pater A. 2002. Loading anticancer drugs intoHDLas well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells. J. Control. Release 80:29-44
152. Wu M, Frieboes HB, McDougall SR, Chaplain MA, Cristini V, Lowengrub J. 2013. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J. Theor. Biol. 320:131-51
153. Bricarello DA, Smilowitz JT, Zivkovic AM, German JB, Parikh AN. 2011. Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures. ACS Nano 5:42-57
154. Lacko AG, Sabnis NA, Nagarajan B, McConathy WJ. 2015. HDL as a drug and nucleic acid delivery vehicle. Front. Pharmacol. 6:247
155. Lou B, Liao XL, WuMP, Cheng PF, YinCY, Fei Z. 2005. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J. Gastroenterol. 11:954-59
156. Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG. 2012. Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles. Int. J. Nanomed. 7:975-83
157. Frias JC, Williams KJ, Fisher EA, Fayad ZA. 2004. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J. Am. Chem. Soc. 126:16316-17
158. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, et al. 2008. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small 4:1437-44
159. Skajaa T, Cormode DP, Falk E, Mulder WJ, Fisher EA, Fayad ZA. 2010. High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30:169-76